Jet2 posted strong profits and revenue with a solid balance sheet, but faces macro risks, and margin pressure. Read why DRTGF ...

Accenture's Reinvention Services reorganization and GenAI momentum are key catalysts for topline acceleration. Read why ACN ...

Despite recent stock gains and India expansion, I dislike NUS's declining revenue and shrinking affiliate network, which ...

San Juan Basin Royalty faces a worsening outlook with falling production, weak gas prices, and financial red flags. See why ...

SCHD offers higher income and diversification but faces growth limits, while VIG favors total return and dividend growth.

Structure Therapeutics has dropped over 55% as its GLP-1 pill targets obesity, yet analysts remain bullish with high price ...

KNOT Offshore Partners is showing signs of recovery, supported by stable long-term leases, rising income, a new dividend, and ...

Gator Capital Management reports strong Q2 gains and sees upside in WEX Inc. amid activist pressure and rate outlook. Read ...

IBHF offers a near-7% yield after expenses, with a portfolio mainly in BB and B-rated bonds. Click here to read more about ...

Superior Group of Companies continues to grow, but the rest of this year will likely be more mixed. Read why maintaining SGC ...

Eli Lilly's Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 92% YoY. Read why LLY stock's recent 20% pullback ...

EXI offers global exposure and less concentration risk than XLI but underperformed. Check out the analysis of the industrial ...